709: SAFETY OF 4-FACTOR PCC FOR REVERSAL OF FXA INHIBITORS VERSUS WARFARIN IN NEUROCRITICAL CARE PATIENTS
Sign Up to like & getrecommendations! Published in 2019 at "Critical Care Medicine"
DOI: 10.1097/01.ccm.0000551460.73571.35
Abstract: Learning Objectives: Posterior reversible encephalopathy syndrome (PRES) is a state of hyperperfusion and endothelial dysfunction that can present with headache, seizure, encephalopathy, visual impairment, severe hypertension, and cerebral edema on magnetic resonance imaging (MRI). We… read more here.
Keywords: pazopanib; pcc reversal; safety factor; 709 safety ... See more keywords